LOS GATOS, Calif., February 11, 2026 – Under the headline, Fluorescent Imaging Demystifies Melanoma, the February issue of The Pathologist features an interview with Orlucent co-founder and Chief Scientific Officer, Cathy Shachaf PhD, in follow-up to the publication of pivotal study results for the Orlucent® Skin Fluorescent Imaging (SFI) System in JAAD International. In the interview, Dr. Shachaf discusses how the in vivo molecular fluorescent imaging system addresses the gap in early melanoma detection of atypical moles and its solid accuracy in differentiating low- from high-risk pigmented lesions. The non-invasive, point of care Orlucent SFI system is designed for use by dermatologists to identify lesions with biological activity indicative of melanoma potential and as additional biological information for pathologists who assess biopsied tissue.